Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Noxopharm Ltd V.NOX


Primary Symbol: NOXOF

Noxopharm Limited is a biotech company. It is engaged in discovering and developing novel treatments for cancer and inflammation, including a pioneering technology to enhance messenger ribonucleic acid (mRNA) vaccines. It utilizes specialist in-house capabilities and partnerships with researchers to build a pipeline of new proprietary drugs based on two technology platforms: Chroma (oncology) and Sofra (inflammation, autoimmunity, and mRNA vaccine enhancement). Chroma is a technology platform focused on the development of multiple drug candidates, primarily for cancer treatment. The Sofra technology platform has a pipeline of proprietary drugs based on oligonucleotides, the building blocks of deoxyribonucleic acid (DNA), with a focus on mRNA vaccines and the treatment of autoimmune and inflammatory diseases. SOF-VAC has applications in the treatment of excessive inflammatory responses associated with specialized inflammatory receptors in the body known as Toll-like receptor 7.


OTCPK:NOXOF - Post by User

Bullboard Posts
Comment by MakeMyDay2on Jan 11, 2010 10:48pm
333 Views
Post# 16666817

RE: RE: RE: Back to the .20s

RE: RE: RE: Back to the .20sThat 0.20 prediction is based on (                ).

If CIBC would'nt of dumped a large # of shares out of the blue, the share price would be above 0.40.  Like the sheeps that follow the first one jumping off the cliff, many shareholders did the same today when they saw CIBC dumping ..., sad but true.

Fortunately enough though,  there was a really good back-up of buyers that believe in Niogold to help bring the stock back.

Look at the size of Niogolds's properties and where they are located. Apart from a producer, it hardly gets better than that and let's put a conservative estimate of, let's say,  600,000 ounces gold. Is it worth more than 0.38 ??? 

OHHHHH YES  !!!!!!!!












 
  
Bullboard Posts